Biotechs as a comparison generally take about 10 years from conception, through to phase trials that take ages (years), then either to commercialisation or bust. So 24 years is a bit of a stretch.............................
Downramping? Hardly. When there are 'professional and sophisticated' investors willing to part with their money that's the sort of support ADO needs, but they will need more so don't criticise the investors willing to support the company? Certainly surprised anyone would knock them? Maybe you need to reflect why you support ADO?
ADO Price at posting:
2.1¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)